⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated cost per beneficiaryHigh antipsychotic prescribing (65+)Extreme fills per patient
Risk indicators are statistical patterns, not allegations. Learn more
53,356
Total Claims
$6.6M
Drug Cost
888
Beneficiaries
$7,419
Cost/Patient
Risk Score Breakdown 21/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+10
High fills per patient+5
Cost per patient outlier+3
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+426%
Cost per patient vs peers
$7,419 vs $1,411 avg
+39%
Brand preference vs peers
14.8% vs 10.6% avg
Brand vs Generic
85% generic
Brand: 7,727 claims · $4.5M
Generic: 44,460 claims · $2.1M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Icosapent Ethyl | 3,141 | $1.4M |
| Cyclosporine | 595 | $468K |
| Metformin Hcl | 80 | $244K |
| Linaclotide | 329 | $212K |
| Lipase/Protease/Amylase | 131 | $179K |
| Semaglutide | 149 | $163K |
| Lactulose | 79 | $155K |
| Ubrogepant | 88 | $151K |
| Dapagliflozin Propanediol | 189 | $144K |
| Dulaglutide | 102 | $133K |
| Tenofovir Alafenamide | 88 | $132K |
| Mesalamine | 201 | $129K |
| Sitagliptin Phosphate | 142 | $120K |
| Halobetasol Propionate | 903 | $117K |
| Lipase/Protease/Amylase | 51 | $107K |
Prescribing Profile
Patient Profile
72
Avg Age
51%
Female
0.94
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About